Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Activant Capital is a private global investment firm focused primarily on backing high-growth companies that are transforming commerce through technology. The firm describes itself as research-led and invests across themes including commerce, fintech, logistics, enterprise software, and related technology sectors. While some third-party sources list healthcare among sectors it may invest in, Activant is not itself a biotech, pharma, or healthcare operating company and does not appear to develop therapeutic products. Founded in 2015, the firm manages approximately $1.5 billion in assets under management and supports portfolio companies with capital, strategic guidance, and network access. For a biotech analyst, Activant is best understood as an investor rather than a life sciences developer, manufacturer, or service provider.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Activant Capital.